ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Toshihiko Aranishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.